Atrasentan
From Self-sufficiency
Revision as of 20:15, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): antineoplastic-drug-stub)
| File:Atrasentan.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
(2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid | |
| Identifiers | |
| CAS Number | 173937-91-2 |
| ATC code | none |
| PubChem | CID 159594 |
| Chemical data | |
| Formula | C29H38N2O6 |
| Molar mass | 510.621 g/mol[[Script error: No such module "String".]] |
Atrasentan is an experimental drug that is being studied for the treatment of various types of cancer[1], including non-small cell lung cancer.[2]
It is an endothelin receptor antagonist selective for subtype A (ETA). While other drugs of this type (sitaxentan, ambrisentan) exploit the vasoconstrictive properties of endothelin and are mainly used for the treatment of pulmonary arterial hypertension, atrasentan blocks endothelin induced cell proliferation.
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
| 35px | This oncology article is a stub. You can help ssf by expanding it. |
- ↑ Atrasentan (entry in the public domain NCI Dictionary of Cancer Terms)
- ↑ Chiappori, AA; Haura, E; Rodriguez, FA; Boulware, D; Kapoor, R; Neuger, AM; Lush, R; Padilla, B; Burton, M (1 March 2008). "Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non–Small Cell Lung Cancer". Clinical Cancer Research. 14 (5): 1464–1469. doi:10.1158/1078-0432.CCR-07-1508. PMID 18316570.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Antineoplastic and immunomodulating drug stubs
- Oncology stubs
